Key Clinical Evidence Phase 2 Randomized Trial in Obesity (48 weeks) Jastreboff AM et al., New England Journal of Medicine, 2023 ClinicalTrials.gov: NCT04881760 The Phase 2 study evaluated multiple doses of retatrutide versus placebo over 48 weeks
Originally developed and increasingly used for the treatment of type 2 diabetes, these medications have proven highly effective in promoting weight loss, at least during treatment, 35 sparking widespread public interest
Patients with kidney issues now have new hope because of semaglutide, a medication that is currently used to treat diabetes and reduce body weight
L-carnitine is a compound made from the amino acids lysine and methionine
Love the products and convenience of VITAstir
While natural amylin disappears from the bloodstream within minutes, cagrilintide maintains therapeutic levels for an entire week